Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients Results from the OVCAD study

E. I. Braicu, C. Fotopoulou, T. Van Gorp, R. Richter, R. Chekerov, C. Hall, H. Butz, D. Cacsire Castillo-Tong, S. Mahner, R. Zeillinger, N. Concin, I. Vergote, J. Sehouli

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)245-251
JournalGynecologic Oncology
Issue number2
Publication statusPublished - Feb 2013


  • Ovarian cancer
  • HE4
  • CA125
  • Surgical outcome

Cite this